Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
GNSZ > SEC Filings for GNSZ > Form 8-K on 23-Oct-2013All Recent SEC Filings

Show all filings for GENSPERA INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for GENSPERA INC


23-Oct-2013

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On October 22, 2013, GenSpera, Inc. announced that Devalingam Mahalingam, MD, PhD, principal investigator of the G-202 Phase II trial in hepatocellular carcinoma (liver cancer), presented final data from the G-202 Phase I clinical on October 21, 2013 at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Boston, MA
(http://www.aacr.org/home/scientists/meetings-workshops/molecular-targets-and-cancer-therapeutics.aspx). A copy of the press release and poster used in the presentation are attached hereto as Exhibits 99.01 and 99.02, respectively.



Item 9.01 Financial Statements and Exhibits.

Exhibit
No.                               Description
99.01     Press Release issued October 22, 2013

99.02     Poster used in connection with October 21, 2013 presentation

  Add GNSZ to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for GNSZ - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.